Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

ZnS Nanoparticles Sensitize Luminescence of Capping-Ligand-Bound Lanthanide Ions.

Tigaa RA, Lucas GJ, de Bettencourt-Dias A.

Inorg Chem. 2017 Mar 20;56(6):3260-3268. doi: 10.1021/acs.inorgchem.6b02638. Epub 2017 Feb 27.

PMID:
28240868
2.

Cognitive synergy in groups and group-to-individual transfer of decision-making competencies.

Cur┼čeu PL, Meslec N, Pluut H, Lucas GJ.

Front Psychol. 2015 Sep 22;6:1375. doi: 10.3389/fpsyg.2015.01375. eCollection 2015.

3.

Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent.

Lucas GJ, Riches PL, Hocking LJ, Cundy T, Nicholson GC, Walsh JP, Ralston SH.

J Bone Miner Res. 2008 Jan;23(1):58-63.

4.

Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders.

Lucas GJ, Daroszewska A, Ralston SH.

J Bone Miner Res. 2006 Dec;21 Suppl 2:P31-7. Review.

5.

Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.

Lucas GJ, Mehta SG, Hocking LJ, Stewart TL, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Watts GD, Ralston SH, Kimonis VE.

Bone. 2006 Feb;38(2):280-5. Epub 2005 Sep 30.

PMID:
16199218
6.

Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.

Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Meier C, Hooper MJ, Ralston SH.

J Bone Miner Res. 2005 Feb;20(2):227-31. Epub 2004 Nov 16.

7.

Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.

Hocking LJ, Lucas GJ, Daroszewska A, Cundy T, Nicholson GC, Donath J, Walsh JP, Finlayson C, Cavey JR, Ciani B, Sheppard PW, Searle MS, Layfield R, Ralston SH.

J Bone Miner Res. 2004 Jul;19(7):1122-7. Epub 2004 Mar 22.

8.

Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.

Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH.

Hum Mol Genet. 2002 Oct 15;11(22):2735-9.

PMID:
12374763
9.

Cerebral dysfunction vs. psychogenesis in Halstead-Reitan tests.

Barnes GW, Lucas GJ.

J Nerv Ment Dis. 1974 Jan;158(1):50-60. No abstract available.

PMID:
4809534
10.

Progressive neuromuscular and skeletal disorders in a male with an acrocentric supernumerary chromosome.

Lehrnbecher W, Lucas GJ, Picciano D, Jacobson CB.

Nature. 1970 Aug 8;227(5258):612-3. No abstract available.

PMID:
5429292
11.

Nasopharyngeal carcinoma with neuro-ophthalmic signs: new aspects of diagnosis and treatment.

Lehrnbecher W, Lucas GJ, Arias-Bernal L, Jacobson CB.

South Med J. 1970 Jun;63(6):727-30. No abstract available.

PMID:
5446236
12.

Chromosomal effects of LSD-25, a controversy?

Lucas GJ, Lehrnbecher W.

J Ark Med Soc. 1970 Mar;66(10):348-9. No abstract available.

PMID:
4244799
13.

Hydroxyurea in nasopharyngeal cancer.

Lucas GJ, Lehrnbecher W.

JAMA. 1969 Dec 29;210(13):2397. No abstract available.

PMID:
5395395
14.

Letters to the editor.

Lehrnbecher W, Lucas GJ.

Science. 1969 Nov 21;166(3908):948-9. No abstract available.

PMID:
17758053
15.

Dermatoglyphics and schizophrenia.

Lucas GJ, Lehrnbecher W.

Br J Psychiatry. 1969 Nov;115(528):1347. No abstract available.

PMID:
5360346
16.

Evaluation of chromosomal changes.

Lucas GJ, Lehrnbecher W.

N Engl J Med. 1969 Oct 30;281(18):1018. No abstract available.

PMID:
5824729
17.

Disorders of brain and connective tissue in a patient with 47,XYY karyotype.

Lehrnbecher W, Lucas GJ.

Lancet. 1969 Oct 11;2(7624):796-7. No abstract available.

PMID:
4186040
18.

PROGRESSIVE SUDOMOTOR DENERVATION AND ADIE'S SYNDROME.

PETAJAN JH, DANFORTH RC, D ALLESIO D, LUCAS GJ.

Neurology. 1965 Feb;15:172-6. No abstract available.

PMID:
14275746
19.

Charcot-Marie-Tooth disease with associated myopathy. A report of a family.

LUCAS GJ, FORSTER FM.

Neurology. 1962 Sep;12:629-36. No abstract available.

PMID:
14467082
20.

Acute intermittent porphyria treated with trifluoperazine.

LEE DF, LUCAS GJ.

U S Armed Forces Med J. 1959 Oct;10:1242-6. No abstract available.

PMID:
14415175

Supplemental Content

Loading ...
Support Center